TheJakartaPost
Please Update your browser
Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.
AstraZeneca to withdraw COVID-19 vaccine globally as demand dips
The company also said it would proceed to withdraw the vaccine Vaxzevria's marketing authorizations within Europe.
Change Size
What a waste: Vials of AstraZeneca COVID-19 vaccine on March 22. As many as 4,000 doses of AstraZeneca vaccines were found expired in Kudus regency, Central Java. (JP/Antara/Syaiful Arif)
A
straZeneca said on Tuesday it had initiatedthe worldwide withdrawal of its COVID-19 vaccine due to a "surplus of available updated vaccines" since the pandemic.
The company also said it would proceed to withdraw the vaccine Vaxzevria's marketing authorizations within Europe.
"As multiple, variant COVID-19 vaccines have since been developed there is a surplus of available updated vaccines," the company said, adding that this had led to a decline in demand for Vaxzevria, which is no longer being manufactured or supplied.
According to media reports, the Anglo-Swedish drugmaker has previously admitted in court documents that the vaccine causes side-effects such as blood clots and low blood platelet counts.
The firm's application to withdraw the vaccine was made on March 5 and came into effect on May 7, according to the Telegraph, which first reported the development.
London-listed AstraZeneca began moving into respiratory syncytial virus vaccines and obesity drugs through several deals last year after a slowdown in growth as COVID-19 medicine sales declined.
Your Opinion Matters
Share your experiences, suggestions, and any issues you've encountered on The Jakarta Post. We're here to listen.
Thank you
Thank you for sharing your thoughts. We appreciate your feedback.
